Dr. Paula Regina Gelinski Kempe is currently a postdoctoral fellow in the Department of Biosciences at SRI International, where she is performing CRISPR screen on the whole genome of the Naked Mole rat, a long-lived animal that presents resistance to several neurological diseases and cancer. She earned a B.S. in Biomedical Sciences in 2016 and a Ph.D. in Cell Biology in 2022 from the University of Campinas, Brazil. During her Ph.D. studies she worked with a model of a spinal cord lesion and adopted different approaches to leverage motor function recovery, neuroprotection, and inflammatory modulation. During this period, she was twice awarded the Brazilian Society for Neuroscience Prize (SBNEC) and the Innovation in Pharmaceutical Sciences Prize. Her work in neurosciences has led to several publications and presentations, including a travel award being granted by the International Society of Neuroimmunology. Her research interests encompass neurodegeneration, neuroregeneration, pharmacological approaches, cellular therapy, gene editing, and precision therapy.
Dr. Paula Regina Gelinski Kempe is currently a postdoctoral fellow in the Department of Biosciences at SRI International, where she is performing CRISPR screen on the whole genome of the Naked Mole rat, a long-lived animal that presents resistance to several neurological diseases and cancer. She earned a B.S. in Biomedical Sciences in 2016 and a Ph.D. in Cell Biology in 2022 from the University of Campinas, Brazil. During her Ph.D. studies she worked with a model of a spinal cord lesion and adopted different approaches to leverage motor function recovery, neuroprotection, and inflammatory modulation. During this period, she was twice awarded the Brazilian Society for Neuroscience Prize (SBNEC) and the Innovation in Pharmaceutical Sciences Prize. Her work in neurosciences has led to several publications and presentations, including a travel award being granted by the International Society of Neuroimmunology. Her research interests encompass neurodegeneration, neuroregeneration, pharmacological approaches, cellular therapy, gene editing, and precision therapy.